A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG
Wuxi People's Hospital
Zhuhai Beihai Biotech Co., Ltd
HighField Biopharmaceuticals Corporation
Tongji Hospital
Affiliated Hospital of Jiangnan University
Chinese PLA General Hospital
Huabo Biopharm Co., Ltd.
Wuxi No. 4 People's Hospital
Wuxi No. 4 People's Hospital
Wuxi No. 4 People's Hospital
Ministry of Health, Malaysia
Hutchmed
Institut Paoli-Calmettes
Tianjin Medical University Second Hospital
The First Affiliated Hospital of Soochow University
Jiangsu HengRui Medicine Co., Ltd.
Ningbo Cancer Hospital